Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Bristol-Myers Squibb appoints Charles Bancroft acting chief financial officer

January 15, 2010 Sales and Marketing BMS, appointment, sales and marketing

Charles Bancroft has been appointed acting chief financial officer at Bristol-Myers Squibb, replacing Jean-Marc Huet who left the company at …
Appointment

European politician attacks “alarmist” pharma industry

January 14, 2010 Sales and Marketing h1n1, swine flu

A European politician has criticised the pharmaceutical industry for creating public health scares and profiting from them. Dr Wolfgang Wodarg …
News

World Class Commissioning: how to be partners in quality

January 14, 2010 Sales and Marketing NHS, NHS funding, commissioning, funding, healthcare, marketing

World Class Commissioning has been heralded as a critical mechanism to revolutionise healthcare services in the UK. Now two years …
Feature

Biogen submits Fampridine PR to European regulators

January 14, 2010 Sales and Marketing Biogen, Fampridine, MS

Biogen Idec is seeking European approval for a drug which helps multiple sclerosis sufferers to walk better. A marketing authorisation …
News

Hans Regenauer joins Sanofi-Aventis’ consumer division

January 14, 2010 Sales and Marketing Sanofi-Aventis, appointment, consumer healthcare, sales and marketing

Sanofi-Aventis has appointed Han Regenauer vice president, consumer healthcare, Europe and global development. In his new role he will report …
Appointment

Germany cuts GSK swine flu vaccine orders by 30%

January 13, 2010 Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1, swine flu

The Germany Ministry of Health has cut its order for GlaxoSmithKline’s swine flu vaccine Pandemrix by 30%. The pharma company …
News

FDA begins consumer transparency initiative

January 13, 2010 Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …
News

Train to retain: holding onto your best people

January 13, 2010 Business Services, Sales and Marketing MSI, careers, training

It’s a widely-held myth that retaining staff is easy in a recession. As jobs are cut the attraction of staying …
Feature

Novartis launches Ilaris in the UK

January 12, 2010 Sales and Marketing Ilaris, Novartis, cryopyrin-associated periodic syndrome

Novartis has launched its new biologic Ilaris in the UK as a treatment for cryopyrin-associated periodic syndrome. The rare debilitating …
News

FDA approves Roche’s Actemra

January 11, 2010 Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis

Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …
News

Alison Clough promoted to commercial and communications director for the ABPI

January 11, 2010 Medical Communications, Research and Development, Sales and Marketing ABPI, appointment, patent box

UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …
Appointment

NICE says no to Multaq

January 8, 2010 Sales and Marketing Multaq, NICE, Sanofi

NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …
News

AstraZeneca’s Bruno Angelici awarded Légion d`honneur

January 8, 2010 Sales and Marketing AstraZeneca, France, appointment, sales and marketing

AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …
Appointment

England moves forward on generic substitution

January 8, 2010 Sales and Marketing NHS, generics, substitution

The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …
News

AstraZeneca signs deals to increase anti-infective portfolio

January 7, 2010 Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026